Gene · 5281
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum placental growth factor, total cholesterol, and triglycerides for prediction of intrahepatic cholestasis of pregnancy. | Medicine (Baltimore) | 2023 | 38115361 | PubTator, text mining | PubMed |
| Mirror syndrome associated with fetal cardiomyopathy. | Arch Clin Cases | 2023 | 38098693 | PubTator, text mining | PubMed |
| Gestational hypertension and risk of atopic diseases in offspring, a national-wide cohort study. | Front Pediatr | 2023 | 38078331 | PubTator, text mining | PubMed |
| Mesenchymal stem cells-based drug delivery systems for diabetic foot ulcer: A review. | World J Diabetes | 2023 | 38077806 | PubTator, text mining | PubMed |
| Potential Roles of microRNAs for Assessing Cardiovascular Risk in Pre-Eclampsia-Exposed Postpartum Women and Offspring. | Int J Mol Sci | 2023 | 38069164 | PubTator, text mining | PubMed |
| Role of Clinical Risk Factors and B-Type Natriuretic Peptide in Assessing the Risk of Asymptomatic Cardiotoxicity in Breast Cancer Patients in Kazakhstan. | Diagnostics (Basel) | 2023 | 38066798 | PubTator, text mining | PubMed |
| Profiling of serum factors associated with Staphylococcus aureus skin and soft tissue infections as a foundation for biomarker identification. | Front Immunol | 2023 | 38054000 | PubTator, text mining | PubMed |
| Endothelial activation and damage as a common pathological substrate in different pathologies and cell therapy complications. | Front Med (Lausanne) | 2023 | 38034541 | PubTator, text mining | PubMed |
| Exploring maternal-fetal interface with in vitro placental and trophoblastic models. | Front Cell Dev Biol | 2023 | 38033854 | PubTator, text mining | PubMed |
| Switching to Conbercept in Diabetic Macular Edema After Unsatisfactory Response to Previous Intravitreal Injection of Ranibizumab. | Clin Ophthalmol | 2023 | 38026602 | PubTator, text mining | PubMed |
| Importance of Determining Vascular Endothelial Growth Factor Serum Levels in Children with Infantile Hemangioma. | Medicina (Kaunas) | 2023 | 38003963 | PubTator, text mining | PubMed |
| Advances in Intercellular Communication Mediated by Exosomal ncRNAs in Cardiovascular Disease. | Int J Mol Sci | 2023 | 38003385 | PubTator, text mining | PubMed |
| sFlt-1 Levels as a Predicting Tool in Placental Dysfunction Complications in Multiple Pregnancies. | Biomedicines | 2023 | 38001918 | PubTator, text mining | PubMed |
| Exploring the Role of Mediterranean and Westernized Diets and Their Main Nutrients in the Modulation of Oxidative Stress in the Placenta: A Narrative Review. | Antioxidants (Basel) | 2023 | 38001771 | PubTator, text mining | PubMed |
| Chemotherapy in pediatric brain tumor and the challenge of the blood-brain barrier. | Cancer Med | 2023 | 37997517 | PubTator, text mining | PubMed |
| Reduced Endothelial Progenitor Cells: A Possible Biomarker for Idiopathic Fetal Growth Restriction in Human Pregnancies. | J Mother Child | 2023 | 37991978 | PubTator, text mining | PubMed |
| Endothelial progenitor cells in pregnancy-related diseases. | Clin Sci (Lond) | 2023 | 37986615 | PubTator, text mining | PubMed |
| Circulating extracellular vesicles in healthy and pathological pregnancies: A scoping review of methodology, rigour and results. | J Extracell Vesicles | 2023 | 37974377 | PubTator, text mining | PubMed |
| Physical exercise for a healthy pregnancy: the role of placentokines and exerkines. | J Physiol Sci | 2023 | 37964253 | PubTator, text mining | PubMed |
| Study of aqueous humour inflammatory mediators' levels in a cohort of Egyptian patients with diabetic macular oedema. | BMC Ophthalmol | 2023 | 37964190 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5281/papers?page=6